The University of Chicago Header Logo

Connection

Robert Wollmann to Humans

This is a "connection" page, showing publications Robert Wollmann has written about Humans.
Connection Strength

0.230
  1. Neuropathological evaluation of an 84-year-old man after 422 ECT treatments. J ECT. 2014 Sep; 30(3):248-50.
    View in: PubMed
    Score: 0.016
  2. Exome sequencing detection of two untranslated GFPT1 mutations in a family with limb-girdle myasthenia. Clin Genet. 2014 Feb; 85(2):166-71.
    View in: PubMed
    Score: 0.014
  3. Synaptic basal lamina-associated congenital myasthenic syndromes. Ann N Y Acad Sci. 2012 Dec; 1275:36-48.
    View in: PubMed
    Score: 0.014
  4. Congenital myasthenic syndrome associated with epidermolysis bullosa caused by homozygous mutations in PLEC1 and CHRNE. Clin Genet. 2011 Nov; 80(5):444-51.
    View in: PubMed
    Score: 0.012
  5. Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction. Hum Mol Genet. 2010 Jun 15; 19(12):2370-9.
    View in: PubMed
    Score: 0.012
  6. Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome. J Med Genet. 2009 Mar; 46(3):203-8.
    View in: PubMed
    Score: 0.011
  7. Congenital myasthenic syndrome caused by two non-N88K rapsyn mutations. Clin Genet. 2007 Jul; 72(1):63-5.
    View in: PubMed
    Score: 0.010
  8. Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering. Muscle Nerve. 2003 Sep; 28(3):293-301.
    View in: PubMed
    Score: 0.007
  9. Choline acetyltransferase mutations in myasthenic syndrome due to deficient acetylcholine resynthesis. Muscle Nerve. 2003 Feb; 27(2):180-7.
    View in: PubMed
    Score: 0.007
  10. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with hypertrophic spinal radiculopathy mimicking neurofibromatosis. Acta Neuropathol. 2003 Feb; 105(2):185-8.
    View in: PubMed
    Score: 0.007
  11. Presynaptic congenital myasthenic syndrome due to quantal release deficiency. Neurology. 2001 Jul 24; 57(2):279-89.
    View in: PubMed
    Score: 0.006
  12. Disseminated histoplasmosis in an infant with acquired immunodeficiency syndrome. J Infect. 1998 Nov; 37(3):298-301.
    View in: PubMed
    Score: 0.005
  13. Presynaptic congenital myasthenic syndrome with altered synaptic vesicle homeostasis linked to compound heterozygous sequence variants in RPH3A. Mol Genet Genomic Med. 2018 05; 6(3):434-440.
    View in: PubMed
    Score: 0.005
  14. The clinical significance of extracellular matrix in gangliogliomas. J Neuropathol Exp Neurol. 1996 Dec; 55(12):1246-52.
    View in: PubMed
    Score: 0.005
  15. Pathological case of the month. Globoid cell leukodystrophy (Krabbe's disease). Arch Pediatr Adolesc Med. 1995 Oct; 149(10):1173-4.
    View in: PubMed
    Score: 0.004
  16. Advanced neuroimaging studies in a patient with brain metastases from transitional cell carcinoma of the bladder. J Neuroimaging. 2014 Jul-Aug; 24(4):429-31.
    View in: PubMed
    Score: 0.004
  17. Histopathologic changes in the extraocular muscle in centronuclear myopathy with a Dynamin 2 mutation. Ophthalmic Genet. 2013 Mar-Jun; 34(1-2):83-6.
    View in: PubMed
    Score: 0.003
  18. Six-week-old with fever and fussiness. Pediatr Infect Dis J. 2012 May; 31(5):538, 544.
    View in: PubMed
    Score: 0.003
  19. LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin. Hum Genet. 2012 Jul; 131(7):1123-35.
    View in: PubMed
    Score: 0.003
  20. Inflammation at the neuromuscular junction in myasthenia gravis. Neurology. 1991 Sep; 41(9):1497-504.
    View in: PubMed
    Score: 0.003
  21. A middle-aged woman with nausea, weight loss, and orthostatic hypotension. Neurology. 2011 Aug 02; 77(5):489-95.
    View in: PubMed
    Score: 0.003
  22. Cellular neuropathology of tuberous sclerosis. Ann N Y Acad Sci. 1991; 615:140-8.
    View in: PubMed
    Score: 0.003
  23. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Immunol. 1990 Nov; 82(2):284-8.
    View in: PubMed
    Score: 0.003
  24. Fatal "hypertensive" intracerebral hemorrhage associated with a cerebral cavernous angioma: case report. Acta Neurochir (Wien). 2011 Feb; 153(2):421-3.
    View in: PubMed
    Score: 0.003
  25. Long-term survival of a patient with glioblastoma. Can J Neurol Sci. 2010 Mar; 37(2):289-92.
    View in: PubMed
    Score: 0.003
  26. A 59 year-old man with sellar lesion. Brain Pathol. 2009 Jan; 19(1):161-2.
    View in: PubMed
    Score: 0.003
  27. Variable phenotypes associated with mutations in DOK7. Muscle Nerve. 2008 Apr; 37(4):448-56.
    View in: PubMed
    Score: 0.003
  28. Calpain activation impairs neuromuscular transmission in a mouse model of the slow-channel myasthenic syndrome. J Clin Invest. 2007 Oct; 117(10):2903-12.
    View in: PubMed
    Score: 0.002
  29. A novel FKRP mutation in congenital muscular dystrophy disrupts the dystrophin glycoprotein complex. Neuromuscul Disord. 2007 Apr; 17(4):285-9.
    View in: PubMed
    Score: 0.002
  30. Activation of apoptotic pathways at muscle fiber synapses is circumscribed and reversible in a slow-channel syndrome model. Neurobiol Dis. 2006 Aug; 23(2):462-70.
    View in: PubMed
    Score: 0.002
  31. N-acetyl-beta-hexosaminidase beta locus defect and juvenile motor neuron disease: a case study. Ann Neurol. 1986 Jun; 19(6):568-72.
    View in: PubMed
    Score: 0.002
  32. Degenerative spine disease : pathologic findings in 985 surgical specimens. Am J Clin Pathol. 2006 Feb; 125(2):193-202.
    View in: PubMed
    Score: 0.002
  33. Trak1 mutation disrupts GABA(A) receptor homeostasis in hypertonic mice. Nat Genet. 2006 Feb; 38(2):245-50.
    View in: PubMed
    Score: 0.002
  34. Ganglioneuromatous paraganglioma of the cauda equina--a pathological case study. Hum Pathol. 2005 Apr; 36(4):444-6.
    View in: PubMed
    Score: 0.002
  35. Focal caspase activation underlies the endplate myopathy in slow-channel syndrome. Ann Neurol. 2004 Mar; 55(3):347-52.
    View in: PubMed
    Score: 0.002
  36. Presynaptic failure of neuromuscular transmission and synaptic remodeling in EA2. Neurology. 2003 Dec 23; 61(12):1743-8.
    View in: PubMed
    Score: 0.002
  37. A family with seizures and minor features of tuberous sclerosis and a novel TSC2 mutation. Neurology. 2003 Aug 12; 61(3):409-12.
    View in: PubMed
    Score: 0.002
  38. Venous angiomas of the posterior fossa should be considered as anomalous venous drainage. Surg Neurol. 1983 Jan; 19(1):26-32.
    View in: PubMed
    Score: 0.002
  39. S-100 protein in granular cell tumors (granular cell myoblastomas). Cancer. 1982 May 01; 49(9):1834-8.
    View in: PubMed
    Score: 0.002
  40. Traumatic aneurysm resulting from insertion of an intracranial pressure monitor. Case illustration. J Neurosurg. 2001 Oct; 95(4):720.
    View in: PubMed
    Score: 0.002
  41. Isolated, primary extranodal Hodgkin's disease of the spine: case report. Neurosurgery. 2001 Aug; 49(2):453-6; discussion 456-7.
    View in: PubMed
    Score: 0.002
  42. Distribution of the neuronal specific protein, 14-3-2, in central nervous system lesions of tuberous sclerosis. Acta Neuropathol. 1981; 53(2):113-7.
    View in: PubMed
    Score: 0.002
  43. Superior sagittal sinus thrombosis diagnosed by computed tomography. Surg Neurol. 1981 Jan; 15(1):11-4.
    View in: PubMed
    Score: 0.002
  44. Foamy cells with oligodendroglial phenotype in childhood ataxia with diffuse central nervous system hypomyelination syndrome. Acta Neuropathol. 2000 Dec; 100(6):635-46.
    View in: PubMed
    Score: 0.002
  45. Distribution of glial fibrillary acidic protein in central nervous system lesions of tuberous sclerosis. Acta Neuropathol. 1980; 52(2):135-40.
    View in: PubMed
    Score: 0.001
  46. Necrotizing myelopathy complicating Hodgkin's disease. Arch Neurol. 1979 Sep; 36(9):583-5.
    View in: PubMed
    Score: 0.001
  47. Genetic manipulation of AChR responses suggests multiple causes of weakness in slow-channel syndrome. Ann N Y Acad Sci. 1998 May 13; 841:167-80.
    View in: PubMed
    Score: 0.001
  48. A morphologic study of central nervous system aging in Hiroshima, Japan. Folia Psychiatr Neurol Jpn. 1978; 32(2):263-75.
    View in: PubMed
    Score: 0.001
  49. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes. J Neuroimmunol. 1998 Jan; 81(1-2):98-108.
    View in: PubMed
    Score: 0.001
  50. Cluster of wound botulism in California: clinical, electrophysiologic, and pathologic study. Muscle Nerve. 1997 Oct; 20(10):1284-95.
    View in: PubMed
    Score: 0.001
  51. Central pontine myelinolysis in a patient with classic heat stroke. Arch Neurol. 1997 Aug; 54(8):935-6.
    View in: PubMed
    Score: 0.001
  52. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet. 1996 Aug; 59(2):400-6.
    View in: PubMed
    Score: 0.001
  53. A transgenic mouse model of the slow-channel syndrome. Muscle Nerve. 1996 Jan; 19(1):79-87.
    View in: PubMed
    Score: 0.001
  54. Clinical and genetic studies of fatal familial insomnia. Neurology. 1995 Jun; 45(6):1068-75.
    View in: PubMed
    Score: 0.001
  55. Function and ultrastructure of the neuromuscular junction in post-polio syndrome. Ann N Y Acad Sci. 1995 May 25; 753:129-37.
    View in: PubMed
    Score: 0.001
  56. The absorption, excretion and metabolic pattern of bromhexine in man after oral and i.v. administration. Arzneimittelforschung. 1975; 25(12):1954-8.
    View in: PubMed
    Score: 0.001
  57. Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme. Cancer Invest. 1995; 13(5):453-9.
    View in: PubMed
    Score: 0.001
  58. The human-severe combined immunodeficiency myasthenic mouse model: a new approach for the study of myasthenia gravis. Ann Neurol. 1993 Jul; 34(1):48-56.
    View in: PubMed
    Score: 0.001
  59. Effector mechanisms of myasthenic antibodies. Ann N Y Acad Sci. 1993 Jun 21; 681:264-73.
    View in: PubMed
    Score: 0.001
  60. The hu-SCID myasthenic mouse. A new tool for the investigation of seronegative myasthenia gravis. Ann N Y Acad Sci. 1993 Jun 21; 681:303-5.
    View in: PubMed
    Score: 0.001
  61. SAG: a Schwann cell membrane glycoprotein. J Neurosci. 1992 Jun; 12(6):2177-85.
    View in: PubMed
    Score: 0.001
  62. Late denervation in patients with antecedent paralytic poliomyelitis. N Engl J Med. 1987 Jul 02; 317(1):7-12.
    View in: PubMed
    Score: 0.001
  63. Post-poliomyelitis syndrome: evidence of ongoing denervation in symptomatic and asymptomatic patients. Birth Defects Orig Artic Ser. 1987; 23(4):237-9.
    View in: PubMed
    Score: 0.001
  64. A variant of Fukuyama congenital muscular dystrophy in a non-Japanese child. Pediatr Neurol. 1986 Sep-Oct; 2(5):290-3.
    View in: PubMed
    Score: 0.001
  65. Calcified basal ganglionic mass 12 years after radiation therapy for medulloblastoma. Surg Neurol. 1984 Apr; 21(4):373-6.
    View in: PubMed
    Score: 0.000
  66. Meningeal sarcomatosis and multiple astrocytomas. Arch Neurol. 1983 Mar; 40(3):179-82.
    View in: PubMed
    Score: 0.000
  67. Neuropathy accompanying IgM lambda monoclonal gammopathy. Acta Neuropathol. 1983; 59(4):255-61.
    View in: PubMed
    Score: 0.000
  68. Muscle acid protease activity in amyotrophic lateral sclerosis: correlation with clinical and pathologic features. Neurology. 1982 Aug; 32(8):901-3.
    View in: PubMed
    Score: 0.000
  69. Myopathy induced by epsilon-aminocaproic acid. Case report. J Neurosurg. 1982 Jul; 57(1):130-4.
    View in: PubMed
    Score: 0.000
  70. Distribution of S-100 protein outside the central nervous system. Brain Res. 1982 Feb 25; 234(2):309-17.
    View in: PubMed
    Score: 0.000
  71. S-100 protein in soft-tissue tumors derived from Schwann cells and melanocytes. Am J Pathol. 1982 Feb; 106(2):261-8.
    View in: PubMed
    Score: 0.000
  72. S-100 protein in human chondrocytes. Nature. 1982 Jan 07; 295(5844):63-4.
    View in: PubMed
    Score: 0.000
  73. Immunologic and virologic studies of measles inclusion body encephalitis in an immunosuppressed host: the relationship to subacute sclerosing panencephalitis. Neurology. 1981 Oct; 31(10):1263-70.
    View in: PubMed
    Score: 0.000
  74. Amyotrophic lateral sclerosis with antecedent poliomyelitis. Arch Neurol. 1980 May; 37(5):312-3.
    View in: PubMed
    Score: 0.000
  75. [Ambroxol, studies of biotransformation in man and determination in biological samples (author's transl)]. Arzneimittelforschung. 1978; 28(5a):904-11.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.